title: Wegener's granulomatosis: ischemic stroke as the first clinical manifestation (case study).
authors.forename: Martin
authors.initials: M
authors.lastname: Bares
authors.forename: Miroslava
authors.initials: M
authors.lastname: Muchová
authors.forename: Michal
authors.initials: M
authors.lastname: Dufek
authors.forename: Jirí
authors.initials: J
authors.lastname: Litzman
authors.forename: Petr
authors.initials: P
authors.lastname: Krupa
authors.forename: Ivan
authors.initials: I
authors.lastname: Rektor
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood / Q000276:immunology; D002545:Brain Ischemia / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D020526:Brain Stem Infarctions / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008526:Medulla Oblongata / Q000473:pathology* / Q000503:physiopathology; D008875:Middle Aged; D009413:Nerve Fibers, Myelinated / Q000473:pathology; D013687:Telencephalon / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D005938:Glucocorticoids; D003520:Cyclophosphamide